Global Active Pharmaceutical Ingredient Market- By Applications

MADISONVILLE, La. - May 27, 2015 - PRLog -- The global active pharmaceutical market is estimated to be worth $182 million by 2020 growing at a CAGR of 7.2% between 2014 and 2020. Each drug formulation has two sub-units: The active ingredient and the excipient or the passive inert compound. The active ingredient in the drug causes the desired effect in the body whether it is mitigation of pain or curing 1223the disease. The large numbers of patent expiries have favored the emerging of new pharmaceutical companies being set up which increases the demand for active pharmaceutical ingredients. There is a large investment being made on healthcare and pharmaceutical research resulting in new drugs, vaccines and antibodies which in turn contribute to the growing API market.

The Active pharmaceutical ingredient market is segmented based on the areas of its applications into Cardiology, Pulmonology, Oncology, Ophthalmology, Neurology and Orthopedics There is an increasing incidence of diseases and a demand for new drugs is in turn creating a demand for active pharmaceutical ingredients in the market. The population suffering from cardiac and pulmonary disorders is growing steadily because of the lifestyle changes and rise in pollution. Oncology is another fast growing segment with higher incidences of cancer and the rising aging population contributes to this. There is also a rise globally in the number of epidemics, demanding larger volumes of drugs. These factors are driving the API market. A large investment is being made not only by the governments but also by the pharmaceutical companies into R&D to discover novel drugs to cure the diseases. The strict rules laid out by the regulating agencies and a highly fragmented market are the only constraints hampering the API market.

The market can be geographically segmented as North American, European, Asia- Pacific and the Rest of the world. The North America has the largest market share because of the higher per capita income and advanced research facilities available. European market closely follows with good healthcare facilities available. Asia-Pacific has the fastest growing market because of the increasing affordability of healthcare facilities and the number of new companies being set up. The other countries in Africa and the Middle East have a growing market because of the outbreak of epidemics in these regions.  Some of the key players in the market are BASF (Germany), Pfizer (USA), Mylan (Netherlands), Sun Pharma (India), Dr. Reddy’s (India), Lonza (Switzerland) and Novartis (Switzerland).

For more information please visit : http://www.mordorintelligence.com/industry-reports/global-active-pharmaceutical-ingredients-api-market-industry